UBS Group raised Exelon's price target and multiple firms increased theirs, following Q2 earnings surpassing estimates.

UBS Group raised Exelon’s price target from $40 to $43, while Jefferies Financial Group initiated coverage with a buy rating at $46. Other firms, including Wells Fargo, Scotiabank, Barclays, and Morgan Stanley, also increased their price targets between $40 and $42. Exelon reported Q2 earnings of $0.47 per share, surpassing estimates of $0.40. The company, with a market cap of $40.29 billion, operates in energy distribution and transmission in the U.S. and Canada.